Technical analysis of 89bio Inc (ETNB) stock chart patterns

While 89bio Inc has underperformed by -2.64%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ETNB rose by 27.24%, with highs and lows ranging from $11.84 to $4.16, whereas the simple moving average jumped by 18.13% in the last 200 days.

On March 14, 2025, Goldman started tracking 89bio Inc (NASDAQ: ETNB) recommending Neutral. A report published by Citigroup on March 13, 2025, Initiated its previous ‘Buy’ rating for ETNB. BofA Securities Initiated an Buy rating on April 22, 2024, and assigned a price target of $30. RBC Capital Mkts January 12, 2024d its ‘Outperform’ rating to ‘Sector Perform’ for ETNB, as published in its report on January 12, 2024. UBS also rated the stock as ‘Buy’.

Analysis of 89bio Inc (ETNB)

89bio Inc’s future performance can be determined with the help of several well-rounded types of analysis and research techniques, with equity being one of the most influential. The goal here is to ensure that your current return on equity of -69.30% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 18.03, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.

The average volume for any stock is also a very valuable indicator of volatility, and ETNB has an average volume of 2.01M. On a monthly basis, the volatility of the stock is set at 5.19%, whereas on a weekly basis, it is put at 4.87%, with a gain of 1.32% over the past seven days. Furthermore, long-term investors anticipate a median target price of $30.30, showing growth from the present price of $9.95, which can serve as yet another indication of whether ETNB is worth investing in or should be passed over.

How Do You Analyze 89bio Inc Shares?

In addition to analyzing the fundamentals, it is also important to look at how many company employees own stock. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 3.20%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 106.17% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.

ETNB shares are owned by institutional investors to the tune of 106.17% at present.

Hot this week

How did Grindr Inc (GRND) fare last session?

While Grindr Inc has overperformed by 0.83%, investors are...

Is Nutanix Inc (NTNX) a threat to investors?

While Nutanix Inc has underperformed by -5.09%, investors are...

Investing in Builders Firstsource Inc (BLDR) might be a great opportunity, but the stock is a bit undervalued

While Builders Firstsource Inc has underperformed by -1.14%, investors...

Can you still get a good price for Workday Inc (WDAY) Shares at this point?

While Workday Inc has underperformed by -0.53%, investors are...

A stock that deserves closer examination: Exact Sciences Corp (EXAS)

While Exact Sciences Corp has overperformed by 0.51%, investors...

Topics

How did Grindr Inc (GRND) fare last session?

While Grindr Inc has overperformed by 0.83%, investors are...

Is Nutanix Inc (NTNX) a threat to investors?

While Nutanix Inc has underperformed by -5.09%, investors are...

Can you still get a good price for Workday Inc (WDAY) Shares at this point?

While Workday Inc has underperformed by -0.53%, investors are...

A stock that deserves closer examination: Exact Sciences Corp (EXAS)

While Exact Sciences Corp has overperformed by 0.51%, investors...

Globalstar Inc (GSAT) presents a great opportunity, but the stock is slightly overvalued

While Globalstar Inc has overperformed by 1.91%, investors are...

Is it possible to buy DocuSign Inc(DOCU) shares at a good price now?

While DocuSign Inc has overperformed by 1.11%, investors are...

Examining Beam Therapeutics Inc (BEAM) stock is warranted

While Beam Therapeutics Inc has underperformed by -0.06%, investors...
spot_img

Related Articles

Popular Categories

spot_imgspot_img
US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.